Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone for threatened miscarriage
ACTRN12611000405910Phase 3Completed
- Sponsor
- Dr Luke McLindon
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in threatened abortion comparing Progesterone with Placebo (2 arms). Primary endpoint: Live birth. Started Feb 2012; status: completed.
02
Drugs
progesterone
03
Conditions
threatened abortion
Beyond the preview
Go deeper on ACTRN12611000405910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000405910.